Cargando…

Optimization and Validation of a Plaque Reduction Neutralization Test for the Detection of Neutralizing Antibodies to Four Serotypes of Dengue Virus Used in Support of Dengue Vaccine Development

A dengue plaque reduction neutralization test (PRNT) to measure dengue serotype–specific neutralizing antibodies for all four virus serotypes was developed, optimized, and validated in accordance with guidelines for validation of bioanalytical test methods using human serum samples from dengue-infec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Timiryasova, Tatyana M., Bonaparte, Matthew I., Luo, Ping, Zedar, Rebecca, Hu, Branda T., Hildreth, Stephen W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Tropical Medicine and Hygiene 2013
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3752766/ https://www.ncbi.nlm.nih.gov/pubmed/23458954 http://dx.doi.org/10.4269/ajtmh.12-0461

Ejemplares similares

Dengue Reporter Virus Particles for Measuring Neutralizing Antibodies against Each of the Four Dengue Serotypes
por: Mattia, Kimberly, et al.
Publicado: (2011)

Induction of Neutralizing Antibodies against Four Serotypes of Dengue Viruses by MixBiEDIII, a Tetravalent Dengue Vaccine
por: Zhao, Hui, et al.
Publicado: (2014)

Influence of FcγRIIa-Expressing Cells on the Assessment of Neutralizing and Enhancing Serum Antibodies Elicited by a Live-Attenuated Tetravalent Dengue Vaccine
por: Byers, Anthony M., et al.
Publicado: (2015)

A potent neutralizing antibody with therapeutic potential against all four serotypes of dengue virus
por: Xu, Meihui, et al.
Publicado: (2017)

Optimization of Flow-Cytometry Based Assay for Measuring Neutralizing Antibody Responses against Each of the Four Dengue Virus Serotypes
por: Sharma, Pragati, et al.
Publicado: (2021)

Natural Strain Variation and Antibody Neutralization of Dengue Serotype 3 Viruses
por: Wahala, Wahala M. P. B., et al.
Publicado: (2010)

Dengue Mosaic Vaccines Enhance Cellular Immunity and Expand the Breadth of Neutralizing Antibody Against All Four Serotypes of Dengue Viruses in Mice
por: Hou, Jue, et al.
Publicado: (2019)

Publisher Correction: A potent neutralizing antibody with therapeutic potential against all four serotypes of dengue virus
por: Xu, Meihui, et al.
Publicado: (2018)

Pediatric Measles Vaccine Expressing a Dengue Antigen Induces Durable Serotype-specific Neutralizing Antibodies to Dengue Virus
por: Brandler, Samantha, et al.
Publicado: (2007)

Variation in dengue virus plaque reduction neutralization testing: systematic review and pooled analysis
por: Rainwater-Lovett, Kaitlin, et al.
Publicado: (2012)

Transplantation of a quaternary structure neutralizing antibody epitope from dengue virus serotype 3 into serotype 4
por: Widman, Douglas G., et al.
Publicado: (2017)

Potent Neutralization Ability of a Human Monoclonal Antibody Against Serotype 1 Dengue Virus
por: Lu, Jiansheng, et al.
Publicado: (2018)

Human dengue virus serotype 2 neutralizing antibodies target two distinct quaternary epitopes
por: Gallichotte, Emily N., et al.
Publicado: (2018)

Plaque reduction neutralization antibody test does not accurately predict protection against dengue infection in Ratchaburi cohort, Thailand
por: Sirivichayakul, Chukiat, et al.
Publicado: (2014)

Defining levels of dengue virus serotype-specific neutralizing antibodies induced by a live attenuated tetravalent dengue vaccine (TAK-003)
por: White, Laura J., et al.
Publicado: (2021)

Neutralization of Dengue Virus Serotypes by Sera from Dengue-Infected Individuals Is Preferentially Directed to Heterologous Serotypes and Not against the Autologous Serotype Present in Acute Infection
por: Auerswald, Heidi, et al.
Publicado: (2021)

Neutralization of antibody-enhanced dengue infection by VIS513, a pan serotype reactive monoclonal antibody targeting domain III of the dengue E protein
por: Budigi, Yadunanda, et al.
Publicado: (2018)

Antibody germline characterization of cross-neutralizing human IgGs against 4 serotypes of dengue virus
por: Pitaksajjakul, Pannamthip, et al.
Publicado: (2014)

Neutralizing Antibodies after Infection with Dengue 1 Virus
por: Guzman, Maria G., et al.
Publicado: (2007)

Broad dengue neutralization in mosquitoes expressing an engineered antibody
por: Buchman, Anna, et al.
Publicado: (2020)

Antibody affinity versus dengue morphology influences neutralization
por: Fibriansah, Guntur, et al.
Publicado: (2021)

Neutralizing Dengue Antibody in Pregnant Thai Women and Cord Blood
por: Khamim, Kriangsak, et al.
Publicado: (2015)

Correction: Broad dengue neutralization in mosquitoes expressing an engineered antibody
por: Buchman, Anna, et al.
Publicado: (2020)

Augmented Zika and Dengue Neutralizing Antibodies Are Associated With Guillain-Barré Syndrome
por: Lynch, Rebecca M, et al.
Publicado: (2019)

A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins
por: Fibriansah, Guntur, et al.
Publicado: (2015)

A New Quaternary Structure Epitope on Dengue Virus Serotype 2 Is the Target of Durable Type-Specific Neutralizing Antibodies
por: Gallichotte, E. N., et al.
Publicado: (2015)

Generation and characterization of cross neutralizing human monoclonal antibody against 4 serotypes of dengue virus without enhancing activity
por: Injampa, Subenya, et al.
Publicado: (2017)

Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor
por: Dussupt, Vincent, et al.
Publicado: (2020)

Virus Reduction Neutralization Test: A Single-Cell Imaging High-Throughput Virus Neutralization Assay for Dengue
por: Whiteman, Melissa C., et al.
Publicado: (2018)

COVID-19 serum can be cross-reactive and neutralizing against the dengue virus, as observed by the dengue virus neutralization test
por: Nath, Himadri, et al.
Publicado: (2022)

Variability in Dengue Titer Estimates from Plaque Reduction Neutralization Tests Poses a Challenge to Epidemiological Studies and Vaccine Development
por: Salje, Henrik, et al.
Publicado: (2014)

Induction of Neutralizing Antibody Response against Four Dengue Viruses in Mice by Intramuscular Electroporation of Tetravalent DNA Vaccines
por: Prompetchara, Eakachai, et al.
Publicado: (2014)

Comparison of the Hemagglutination Inhibition Test and IgG ELISA in Categorizing Primary and Secondary Dengue Infections Based on the Plaque Reduction Neutralization Test
por: Lukman, Nurhayati, et al.
Publicado: (2016)

Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody
por: Halstead, SB, et al.
Publicado: (1977)

Autophagy-associated dengue vesicles promote viral transmission avoiding antibody neutralization
por: Wu, Yan-Wei, et al.
Publicado: (2016)

Viridot: An automated virus plaque (immunofocus) counter for the measurement of serological neutralizing responses with application to dengue virus
por: Katzelnick, Leah C., et al.
Publicado: (2018)

Development and Characterization of a Reverse Genetic System for Studying Dengue Virus Serotype 3 Strain Variation and Neutralization
por: Messer, William B., et al.
Publicado: (2012)

Characterization of a Novel Dengue Serotype 4 Virus-Specific Neutralizing Epitope on the Envelope Protein Domain III
por: Ji, Guang-Hui, et al.
Publicado: (2015)

Concurrent infections by all four dengue virus serotypes during an outbreak of dengue in 2006 in Delhi, India
por: Bharaj, Preeti, et al.
Publicado: (2008)

Nanoparticle delivery of a tetravalent E protein subunit vaccine induces balanced, type-specific neutralizing antibodies to each dengue virus serotype
por: Metz, Stefan W., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4hhevrosvnf0lmmb2q11vbdiun